FEATURED POST

'Express lane to death': Texas seeks approval to speed up death penalty appeals, execute more quickly

Image
Texas is seeking to speed up executions with a renewed request to opt-in to a federal law that would shorten the legal process and limit appeals options for death-sentenced prisoners.
Defense attorneys worry it would lead to the execution of innocent people and - if it's applied retroactively, as Texas is requesting - it could potentially end ongoing appeals for a number of death row prisoners and make them eligible for execution dates.
"Opt-in would speed up the death penalty treadmill exponentially," said Kathryn Kase, an longtime defense attorney and former executive director of Texas Defender Services.
But a state attorney general spokeswoman framed the request to the Justice Department as a necessary way to avoid "stressful delays" and cut down on the "excessive costs" of lengthy federal court proceedings.
Robbie Kaplan, co-founder of the #TimesUp movement, says sweeping changes to laws in recent years have dissuaded attorneys from taking on har…

Pfizer Says Execution Drugs Sold to Arkansas Without Knowing

Pfizer Inc. said drugs that can be used to execute inmates by lethal injection were sold to the Arkansas Department of Corrections without its knowledge by the distributor McKesson Corp., in violation of the drugmaker’s policy.

The statement followed a report in the New Yorker that the state of Arkansas was planning to execute seven people before the end of April, after which the lethal injection drugs will expire.

Pfizer and other companies have attempted to block the use of their products in lethal injections. In this case, according to Pfizer, the drugs were sold to the state by San Francisco-based McKesson, one of the U.S.’s largest distributors of pharmaceuticals.

“Without Pfizer’s knowledge, McKesson, a distributor, sold the product to” the Arkansas Department of Corrections, Pfizer said in a statement. “This was in direct violation of our policy.” The drugmaker said it twice asked the state to return the drugs.

“We considered other means by which to secure the return of the product, up to and including legal action,” Pfizer said in the statement. “After careful consideration, we determined that it was highly unlikely that any of these means would secure the timely return of the product and thereby prevent this misuse.”

In a statement Thursday, McKesson also said that Arkansas “intentionally sought to circumvent McKesson’s policies” and that vercuronium bromide was procured “under the auspices that it would be used for medical purposes.” McKesson requested that the product be returned and refunded, Kristin Hunter, a spokeswoman, said in the statement. The company is now considering “all possible means by which to secure the return of the product, up to and including legal action.”

The Arkansas Department of Corrections didn’t respond to a request for comment made after business hours. Rachel Hooper, a spokeswoman for New York-based Pfizer, declined to say whether Pfizer would take any other action against McKesson for violating the policy.

Source: Bloomberg, April 14, 2017

⚑ | Report an error, an omission, a typo; suggest a story or a new angle to an existing story; submit a piece, a comment; recommend a resource; contact the webmaster, contact us: deathpenaltynews@gmail.com.


Opposed to Capital Punishment? Help us keep this blog up and running! DONATE!

Most Viewed (Last 7 Days)

Iran: Execution Of A Sports Coach In Hamadan

Warden Describes Life on Texas Death Row in Delacruz Testimony

20 Minutes to Death: Record of the Last Execution in France

Alabama executes Walter Moody

California has over 700 people on death row and executions could begin soon

Number of Beheadings in Saudi Arabia Rises by 70%

California death row inmate to be freed; no retrial planned

Oklahoma Officials Endorse Nitrogen Executions As 'Humane,' But Some Medical Experts Aren't Sure

Aging death row: Is executing old or infirm inmates cruel?

Two Germans to be caned, jailed for Singapore train graffiti